Back to Careers

Juvena’s Head of Data Science, Dr. Eddie Moler interviewed about his experiences in data science and AI applied to diagnostics and drug discovery and shares why he is excited about Juvena

Back to Careers

National Institute of Aging showcases Juvena Therapeutics

Back to Careers

Longevity Technology Spotlights the Early Beginnings and Future Vision of Juvena Therapeutics

Back to Careers

Juvena’a CEO, Dr. Hanadie Yousef discusses “Harnessing the Regenerative Secretome of Human Pluripotent Stem Cells” with other industry leaders discussing key areas of innovation advancing human healthspan and longevity at the Second Annual Longevity Summit

Back to Careers

Juvena’s lead drug discovery Scientist, Dr. Thach Mai, gave an excellent lecture, “Mapping Secreted Proteins to Unmet Medical Needs” to graduate students at Maastricht Centre for Systems Biology (MaCSBio).  Dr. Mai outlined Juvena’s use of machine learning and computational tools to unravel the therapeutic potential of stem cell-secreted human proteins

Back to Careers

Stanford University welcomed CEO Dr. Hanadie Yousef as a guest lecturer to share her journey in launching Juvena Therapeutics

Back to Careers

Juvena CEO, Hanadie Yousef, Explores the Future of the Intersection of Technology and Biology Alongside Silicon Valley Entrepreneurs with Middle East & Northern African roots at the Annual TechWadi Forum

Back to Careers

Biocom California Names Juvena CEO Hanadie Yousef as One of Ten Recipients of Its 7th Annual Catalyst Award, Recognizing the Most Inspiring and Driven Minds Sparking Meaningful Change to Human Health

Back to Careers

The Wall Street Journal Discusses Juvena’s Series A and Its Potential to Expand the Range of Treatments for Chronic Conditions and Disease of Aging

Back to Careers

Juvena Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases